Search research articles
Contact Us
Filters
Showing results (1-10 of 104) with videos related to
Page
of 11
Sort By:
BJU International
|
February 1, 2022
Off-clamp partial nephrectomy: Level 1 data regarding real-world utility (or futility)
Steven C Campbell, Yosuke Yasuda
International Journal of Urology : Official Journal of the Japanese Urological Association
|
July 29, 2025
Editorial Comment to "Effects of Modifying Hinotori Surgical Robot System on the Surgical Step of the Dissection of the Renal Hilum and the Kidney Isolation"
Soichiro Yoshida, Yosuke Yasuda, Yasuhisa Fujii
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology
|
June 10, 2014
[Three cases of IgG4-related focal retroperitoneal fibrosis]
Yosuke Yasuda, Aki Iwai, Yukinori Inadome, et al.
BMC Musculoskeletal Disorders
|
May 24, 2018
Pharmacological effects of N-[2-[[2-[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]ethyl]hyaluronamide (diclofenac Etalhyaluronate, SI-613), a novel sodium hyaluronate derivative chemically linked with diclofenac
Keiji Yoshioka, Tomochika Kisukeda, Ryoji Zuinen, et al.
Scientific Reports
|
September 26, 2019
Bankruptcy is an inevitable fate of repeated investments with leverage
Momoka Nii, Takuya Okabe, Hiromu Ito, et al.
International Urology and Nephrology
|
December 19, 2025
Restricted mean survival time comparison of olaparib plus abiraterone versus talazoparib plus enzalutamide in first-line metastatic castration-resistant prostate cancer: indirect analyses of propel and talapro-2
Yosuke Yasuda, Soichiro Yoshida, Shugo Yajima, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
October 7, 2025
Indirect Comparison of PROpel and TALAPRO-2 Trials Using the Shiny Method: A Comparative Analysis in Metastatic Castration-Resistant Prostate Cancer
Yosuke Yasuda, Zijie Wang, Soichiro Yoshida, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
December 3, 2025
Bayesian Reanalysis of Adjuvant Nivolumab in Japanese Patients With High-Risk Muscle-Invasive Urothelial Carcinoma
Yosuke Yasuda, Soichiro Yoshida, Shugo Yajima, et al.
Japanese Journal of Clinical Oncology
|
April 14, 2026
Bayesian interpretation of febrile neutropenia risk and primary granulocyte colony-stimulating factor prophylaxis during darolutamide triplet therapy
Hiroshi Fukushima, Soichiro Yoshida, Akihiro Hirakawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
September 23, 2014
Do testosterone levels have prognostic significance in patients with metastatic prostate cancer treated with combined androgen blockade?
Yosuke Yasuda, Yasuhisa Fujii, Takeshi Yuasa, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 104) with videos related to
Sort By:
Page
of 11
BJU International
|
February 1, 2022
Off-clamp partial nephrectomy: Level 1 data regarding real-world utility (or futility)
Steven C Campbell, Yosuke Yasuda
International Journal of Urology : Official Journal of the Japanese Urological Association
|
July 29, 2025
Editorial Comment to "Effects of Modifying Hinotori Surgical Robot System on the Surgical Step of the Dissection of the Renal Hilum and the Kidney Isolation"
Soichiro Yoshida, Yosuke Yasuda, Yasuhisa Fujii
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology
|
June 10, 2014
[Three cases of IgG4-related focal retroperitoneal fibrosis]
Yosuke Yasuda, Aki Iwai, Yukinori Inadome, et al.
BMC Musculoskeletal Disorders
|
May 24, 2018
Pharmacological effects of N-[2-[[2-[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]ethyl]hyaluronamide (diclofenac Etalhyaluronate, SI-613), a novel sodium hyaluronate derivative chemically linked with diclofenac
Keiji Yoshioka, Tomochika Kisukeda, Ryoji Zuinen, et al.
Scientific Reports
|
September 26, 2019
Bankruptcy is an inevitable fate of repeated investments with leverage
Momoka Nii, Takuya Okabe, Hiromu Ito, et al.
International Urology and Nephrology
|
December 19, 2025
Restricted mean survival time comparison of olaparib plus abiraterone versus talazoparib plus enzalutamide in first-line metastatic castration-resistant prostate cancer: indirect analyses of propel and talapro-2
Yosuke Yasuda, Soichiro Yoshida, Shugo Yajima, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
October 7, 2025
Indirect Comparison of PROpel and TALAPRO-2 Trials Using the Shiny Method: A Comparative Analysis in Metastatic Castration-Resistant Prostate Cancer
Yosuke Yasuda, Zijie Wang, Soichiro Yoshida, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
December 3, 2025
Bayesian Reanalysis of Adjuvant Nivolumab in Japanese Patients With High-Risk Muscle-Invasive Urothelial Carcinoma
Yosuke Yasuda, Soichiro Yoshida, Shugo Yajima, et al.
Japanese Journal of Clinical Oncology
|
April 14, 2026
Bayesian interpretation of febrile neutropenia risk and primary granulocyte colony-stimulating factor prophylaxis during darolutamide triplet therapy
Hiroshi Fukushima, Soichiro Yoshida, Akihiro Hirakawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
September 23, 2014
Do testosterone levels have prognostic significance in patients with metastatic prostate cancer treated with combined androgen blockade?
Yosuke Yasuda, Yasuhisa Fujii, Takeshi Yuasa, et al.
Page
of 11